Blog Topic: COVID19

• 

  Risk Factors for COVID-19 In-Hospital Mortality

  January 19, 2021

  Obesity, male sex, diabetes and old age are common risk factors for in-hospital mortality--but have some uncommon attributes in patients with COVID-19

  COVID-19
• 

  Taking a Team Approach to Wellness

  December 18, 2020

  Studies have shown that more than 60% of practitioners exhibit symptoms of burnout. Neurologists are no strangers to this condition.

  COVID-19 Neurology
• 

  Determining What’s Next for Teleneurology

  December 17, 2020

  Lawrence Wechsler, MD, has spent the past decade working to overcome the myriad of barriers that prevented widespread adoption of teleneurology. He then watched the COVID-19 pandemic crush every one of them in mere weeks.

  Neurology COVID-19
• 

  Untangling the Myths and Mysteries of COVID-19

  December 17, 2020

  Brett L. Cucchiara, MD, estimates that a study he co-authored earlier this year, Acute Cerebrovascular Events in Hospitalized COVID-19 Patients, would have taken a year or more to conduct under normal circumstances. Instead, it took two months.

  COVID-19 Neurology
• 

  Testing for Active and Past Infection with SARS-CoV-2 at Penn Medicine

  December 09, 2020

  Penn Medicine continues to test patients for SARS-CoV-2 and report research developments as the public awaits a vaccine.

  COVID-19
• 

  INOVIO COVID-19 Vaccine Trial Update

  December 07, 2020

  Penn is participating in the clinical trial to evaluate INO-4800, an investigational DNA Vaccine

  COVID-19
• 

  The Long Haul Ahead: A Penn Nursing Investigation of Home Healthcare for COVID Survivors in the Community

  December 04, 2020

  Researchers at Penn Nursing recently investigated patients in the community after hospitalization for COVID-19 to elucidate the value of home healthcare

  COVID-19 Primary Care
• 

  Dexamethasone and COVID-19: The Randomized Evaluation of COVID-19 Therapy (RECOVERY) Trial

  November 13, 2020

  The Randomized Evaluation of COVID-19 Therapy (RECOVERY) study evaluated immunosuppressant therapy in SARS-Co-V2.

  COVID-19 Immunotherapy Pulmonology
• 

  Remdesivir: FDA Approved for COVID-19

  October 25, 2020

  Remdesivir is the first drug to receive the FDA's endorsement for treatment of COVID-19 requiring hospitalization.

  COVID-19
• 

  Alveolar Epithelial Regeneration Following Acute Lung Injury

  October 13, 2020

  Penn Medicine researchers investigate alveolar epithelial regeneration, how it can be utilized after COVID-19 disease, and become a potential human lung regeneration strategy.

  Pulmonology COVID-19